{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:38:38Z","timestamp":1794584318432,"version":"4.9.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Lorna and Yuti Chernajovsky Foundation","award":["PhD2021"],"award-info":[{"award-number":["PhD2021"]}]},{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"publisher","award":["22855"],"award-info":[{"award-number":["22855"]}],"id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-025-03700-x","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T07:35:24Z","timestamp":1768203324000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Interleukin-6 blockade modulates monocyte recruitment to protect against diastolic dysfunction associated with inflammatory arthritis"],"prefix":"10.1186","volume":"28","author":[{"given":"Marilena","family":"Christoforou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Perretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"issue":"10354","key":"3700_CR1","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S0140-6736(22)01349-6","volume":"400","author":"N Conrad","year":"2022","unstructured":"Conrad N, Verbeke G, Molenberghs G, Goetschalckx L, Callender T, Cambridge G, et al. Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. Lancet. 2022;400(10354):733\u201343.","journal-title":"Lancet"},{"issue":"10","key":"3700_CR2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014661","volume":"9","author":"MJ Ahlers","year":"2020","unstructured":"Ahlers MJ, Lowery BD, Farber-Eger E, Wang TJ, Bradham W, Ormseth MJ, et al. Heart failure risk associated with rheumatoid arthritis-related chronic inflammation. J Am Heart Assoc. 2020;9(10):e014661.","journal-title":"J Am Heart Assoc"},{"key":"3700_CR3","doi-asserted-by":"publisher","unstructured":"Taylor PC, Atzeni F, Balsa A, Gossec L, M\u00fcller-Ladner U, Pope J. The key comorbidities in patients with rheumatoid arthritis: a narrative review. J Clin Med. 2021;10(3):509. https:\/\/doi.org\/10.3390\/jcm10030509.","DOI":"10.3390\/jcm10030509"},{"issue":"6","key":"3700_CR4","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s11897-024-00682-w","volume":"21","author":"A Zambrano Zambrano","year":"2024","unstructured":"Zambrano Zambrano A, Del R\u00edo Zanatta H, Gonz\u00e1lez Espinoza A, Bernal Alferes B, Zambrano Zambrano K, Martinez Salazar J, et al. Heart failure in rheumatoid arthritis: clinical implications. Curr Heart Fail Rep. 2024;21(6):530\u201340.","journal-title":"Curr Heart Fail Rep"},{"issue":"11","key":"3700_CR5","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/CIRCRESAHA.119.313572","volume":"124","author":"MA Pfeffer","year":"2019","unstructured":"Pfeffer MA, Shah AM, Borlaug BA. Heart failure with preserved ejection fraction in perspective. Circ Res. 2019;124(11):1598\u2013617.","journal-title":"Circ Res"},{"issue":"10","key":"3700_CR6","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1038\/s41591-023-02567-2","volume":"29","author":"CSP Lam","year":"2023","unstructured":"Lam CSP, Docherty KF, Ho JE, McMurray JJV, Myhre PL, Omland T. Recent successes in heart failure treatment. Nat Med. 2023;29(10):2424\u201337.","journal-title":"Nat Med"},{"key":"3700_CR7","doi-asserted-by":"publisher","unstructured":"Chen J, Norling LV, Cooper D. Cardiac dysfunction in rheumatoid arthritis: the role of inflammation. Cells. 2021;10(4):881. https:\/\/doi.org\/10.3390\/cells10040881.","DOI":"10.3390\/cells10040881"},{"issue":"10","key":"3700_CR8","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.3899\/jrheum.131540","volume":"41","author":"H Kobayashi","year":"2014","unstructured":"Kobayashi H, Kobayashi Y, Giles JT, Yoneyama K, Nakajima Y, Takei M. Tocilizumab treatment increases left ventricular ejection fraction and decreases left ventricular mass index in patients with rheumatoid arthritis without cardiac symptoms: assessed using 3.0 tesla cardiac magnetic resonance imaging. J Rheumatol. 2014;41(10):1916\u201321.","journal-title":"J Rheumatol"},{"issue":"12","key":"3700_CR9","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.3899\/jrheum.180065","volume":"45","author":"H Kobayashi","year":"2018","unstructured":"Kobayashi H, Kobayashi Y, Yokoe I, Kitamura N, Nishiwaki A, Takei M, et al. Heart rate-corrected QT interval duration in rheumatoid arthritis and its reduction with treatment with the interleukin 6 inhibitor tocilizumab. J Rheumatol. 2018;45(12):1620\u20137.","journal-title":"J Rheumatol"},{"issue":"1","key":"3700_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/art.41095","volume":"72","author":"JT Giles","year":"2020","unstructured":"Giles JT, Sattar N, Gabriel S, Ridker PM, Gay S, Warne C, et al. Cardiovascular safety of tocilizumab versus etanercept in rheumatoid arthritis: a randomized controlled trial. Arthritis Rheumatol. 2020;72(1):31\u201340.","journal-title":"Arthritis Rheumatol"},{"issue":"43","key":"3700_CR11","doi-asserted-by":"publisher","first-page":"4420","DOI":"10.1093\/eurheartj\/ehab389","volume":"42","author":"C Withaar","year":"2021","unstructured":"Withaar C, Lam CSP, Schiattarella GG, de Boer RA, Meems LMG. Heart failure with preserved ejection fraction in humans and mice: embracing clinical complexity in mouse models. Eur Heart J. 2021;42(43):4420\u201330.","journal-title":"Eur Heart J"},{"issue":"1","key":"3700_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.55563\/clinexprheumatol\/l4nnv0","volume":"40","author":"R Le Roux","year":"2022","unstructured":"Le Roux R, Mokotedi L, Fourie S, Manilall A, Gunter S, Millen AME. TNF-\u03b1 inhibitors reduce inflammation-induced concentric remodelling, but not diastolic dysfunction in collagen-induced arthritis. Clin Exp Rheumatol. 2022;40(1):24\u201332.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"3700_CR13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1161\/HYPERTENSIONAHA.109.148635","volume":"56","author":"GC Mel\u00e9ndez","year":"2010","unstructured":"Mel\u00e9ndez GC, McLarty JL, Levick SP, Du Y, Janicki JS, Brower GL. Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats. Hypertension. 2010;56(2):225\u201331.","journal-title":"Hypertension"},{"issue":"5","key":"3700_CR14","doi-asserted-by":"publisher","first-page":"e35144","DOI":"10.1371\/journal.pone.0035144","volume":"7","author":"F Ma","year":"2012","unstructured":"Ma F, Li Y, Jia L, Han Y, Cheng J, Li H, et al. Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF \u03b2\/Smad activation and cardiac fibrosis induced by Angiotensin II. PLoS One. 2012;7(5):e35144.","journal-title":"PLoS One"},{"issue":"5","key":"3700_CR15","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0092-8674(00)81989-3","volume":"87","author":"V Kouskoff","year":"1996","unstructured":"Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D. Organ-specific disease provoked by systemic autoimmunity. Cell. 1996;87(5):811\u201322.","journal-title":"Cell"},{"key":"3700_CR16","doi-asserted-by":"crossref","unstructured":"Chen J, Norling LV, Mesa JG, Silva MP, Burton SE, Reutelingsperger C, et al. Annexin A1 attenuates cardiac diastolic dysfunction in mice with inflammatory arthritis. Proc Natl Acad Sci U S A. 2021;118(38):e2020385118.","DOI":"10.1073\/pnas.2020385118"},{"issue":"1","key":"3700_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00296-010-1552-9","volume":"31","author":"H Yoshida","year":"2011","unstructured":"Yoshida H, Hashizume M, Mihara M. IL-6 blockade preferentially inhibits Th17 differentiation in collagen-induced arthritis. Rheumatol Int. 2011;31(1):127\u201331.","journal-title":"Rheumatol Int"},{"issue":"2","key":"3700_CR18","first-page":"188","volume":"4","author":"GT Gardner","year":"2019","unstructured":"Gardner GT, Travers JG, Qian J, Liu GS, Haghighi K, Robbins N, et al. Phosphorylation of Hsp20 promotes fibrotic remodeling and heart failure. JACC: Basic to Translational Science. 2019;4(2):188\u201399.","journal-title":"JACC: Basic to Translational Science"},{"issue":"3","key":"3700_CR19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0165-2478(02)00202-X","volume":"84","author":"M Okazaki","year":"2002","unstructured":"Okazaki M, Yamada Y, Nishimoto N, Yoshizaki K, Mihara M. Characterization of anti-mouse interleukin-6 receptor antibody. Immunol Lett. 2002;84(3):231\u201340.","journal-title":"Immunol Lett"},{"issue":"3","key":"3700_CR20","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/cvr\/cvq078","volume":"87","author":"M Kobara","year":"2010","unstructured":"Kobara M, Noda K, Kitamura M, Okamoto A, Shiraishi T, Toba H, et al. Antibody against interleukin-6 receptor attenuates left ventricular remodelling after myocardial infarction in mice. Cardiovasc Res. 2010;87(3):424\u201330.","journal-title":"Cardiovasc Res"},{"issue":"12","key":"3700_CR21","doi-asserted-by":"publisher","first-page":"e0167195","DOI":"10.1371\/journal.pone.0167195","volume":"11","author":"MH Hartman","year":"2016","unstructured":"Hartman MH, Vreeswijk-Baudoin I, Groot HE, van de Kolk KW, de Boer RA, Mateo Leach I, et al. Inhibition of Interleukin-6 Receptor in a Murine Model of Myocardial Ischemia-Reperfusion. PLoS ONE. 2016;11(12):e0167195.","journal-title":"PLoS ONE"},{"issue":"2","key":"3700_CR22","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1084\/jem.20171274","volume":"215","author":"M Hulsmans","year":"2018","unstructured":"Hulsmans M, Sager HB, Roh JD, Valero-Mu\u00f1oz M, Houstis NE, Iwamoto Y, et al. Cardiac macrophages promote diastolic dysfunction. J Exp Med. 2018;215(2):423\u201340.","journal-title":"J Exp Med"},{"issue":"5","key":"3700_CR23","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1164\/rccm.201106-0965OC","volume":"185","author":"AC Mackinnon","year":"2012","unstructured":"Mackinnon AC, Gibbons MA, Farnworth SL, Leffler H, Nilsson UJ, Delaine T, et al. Regulation of transforming growth factor-\u03b21-driven lung fibrosis by galectin-3. Am J Respir Crit Care Med. 2012;185(5):537\u201346.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"3700_CR24","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/ehf2.13174","volume":"8","author":"TD Trippel","year":"2021","unstructured":"Trippel TD, Mende M, D\u00fcngen HD, Hashemi D, Petutschnigg J, Nolte K, et al. The diagnostic and prognostic value of galectin-3 in patients at risk for heart failure with preserved ejection fraction: results from the DIAST-CHF study. ESC Heart Fail. 2021;8(2):829\u201341.","journal-title":"ESC Heart Fail"},{"issue":"6","key":"3700_CR25","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s00395-024-01074-w","volume":"119","author":"JD Lanzer","year":"2024","unstructured":"Lanzer JD, Wienecke LM, Ramirez Flores RO, Zylla MM, Kley C, Hartmann N, et al. Single-cell transcriptomics reveal distinctive patterns of fibroblast activation in heart failure with preserved ejection fraction. Basic Res Cardiol. 2024;119(6):1001\u201328.","journal-title":"Basic Res Cardiol"},{"issue":"12","key":"3700_CR26","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1161\/CIRCRESAHA.124.323892","volume":"134","author":"N Cadosch","year":"2024","unstructured":"Cadosch N, Gil-Cruz C, Perez-Shibayama C, Ludewig B. Cardiac fibroblastic niches in homeostasis and inflammation. Circ Res. 2024;134(12):1703\u201317.","journal-title":"Circ Res"},{"issue":"7760","key":"3700_CR27","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41586-019-1263-7","volume":"570","author":"AP Croft","year":"2019","unstructured":"Croft AP, Campos J, Jansen K, Turner JD, Marshall J, Attar M, et al. Distinct fibroblast subsets drive inflammation and damage in arthritis. Nature. 2019;570(7760):246\u201351.","journal-title":"Nature"},{"issue":"14","key":"3700_CR28","doi-asserted-by":"publisher","first-page":"5618","DOI":"10.1073\/pnas.1221972110","volume":"110","author":"P Sirish","year":"2013","unstructured":"Sirish P, Li N, Liu JY, Lee KS, Hwang SH, Qiu H, et al. Unique mechanistic insights into the beneficial effects of soluble epoxide hydrolase inhibitors in the prevention of cardiac fibrosis. Proc Natl Acad Sci U S A. 2013;110(14):5618\u201323.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"3700_CR29","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.yjmcc.2010.05.005","volume":"49","author":"SB Haudek","year":"2010","unstructured":"Haudek SB, Cheng J, Du J, Wang Y, Hermosillo-Rodriguez J, Trial J, et al. Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy. J Mol Cell Cardiol. 2010;49(3):499\u2013507.","journal-title":"J Mol Cell Cardiol"},{"key":"3700_CR30","doi-asserted-by":"publisher","first-page":"119824","DOI":"10.1016\/j.biomaterials.2020.119824","volume":"236","author":"Y Li","year":"2020","unstructured":"Li Y, Song D, Mao L, Abraham DM, Bursac N. Lack of Thy1 defines a pathogenic fraction of cardiac fibroblasts in heart failure. Biomaterials. 2020;236:119824.","journal-title":"Biomaterials"},{"issue":"23","key":"3700_CR31","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1161\/CIRCULATIONAHA.117.033144","volume":"137","author":"LA Meier","year":"2018","unstructured":"Meier LA, Auger JL, Engelson BJ, Cowan HM, Breed ER, Gonzalez-Torres MI, et al. CD301b\/MGL2(+) mononuclear phagocytes orchestrate autoimmune cardiac valve inflammation and fibrosis. Circulation. 2018;137(23):2478\u201393.","journal-title":"Circulation"},{"key":"3700_CR32","doi-asserted-by":"crossref","unstructured":"Alter C, Henseler AS, Owenier C, Hesse J, Ding Z, Lautwein T, et al. IL-6 in the infarcted heart is preferentially formed by fibroblasts and modulated by purinergic signaling. J Clin Invest. 2023;33(11):e163799.","DOI":"10.1172\/JCI163799"},{"issue":"12","key":"3700_CR33","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.2337\/diabetes.53.12.3209","volume":"53","author":"H Staiger","year":"2004","unstructured":"Staiger H, Staiger K, Stefan N, Wahl HG, Machicao F, Kellerer M, et al. Palmitate-induced interleukin-6 expression in human coronary artery endothelial cells. Diabetes. 2004;53(12):3209\u201316.","journal-title":"Diabetes"},{"issue":"4","key":"3700_CR34","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1161\/01.CIR.99.4.546","volume":"99","author":"M Gwechenberger","year":"1999","unstructured":"Gwechenberger M, Mendoza LH, Youker KA, Frangogiannis NG, Smith CW, Michael LH, et al. Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation. 1999;99(4):546\u201351.","journal-title":"Circulation"},{"issue":"3","key":"3700_CR35","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1152\/japplphysiol.00576.2020","volume":"130","author":"KM Huffman","year":"2021","unstructured":"Huffman KM, Andonian BJ, Abraham DM, Bareja A, Lee DE, Katz LH, et al. Exercise protects against cardiac and skeletal muscle dysfunction in a mouse model of inflammatory arthritis. J Appl Physiol. 2021;130(3):853\u201364.","journal-title":"J Appl Physiol"},{"issue":"11","key":"3700_CR36","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018549","volume":"10","author":"YC Chia","year":"2021","unstructured":"Chia YC, Kieneker LM, Hassel GV, Binnenmars SH, Nolte IM, Zanden JJV, et al. Interleukin 6 and development of heart failure with preserved ejection fraction in the general population. J Am Heart Assoc. 2021;10(11):e018549.","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"3700_CR37","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1046\/j.1365-2362.2003.01252.x","volume":"33","author":"BS Chin","year":"2003","unstructured":"Chin BS, Blann AD, Gibbs CR, Chung NA, Conway DG, Lip GY. Prognostic value of interleukin-6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor and vascular endothelial growth factor levels in congestive heart failure. Eur J Clin Invest. 2003;33(11):941\u20138.","journal-title":"Eur J Clin Invest"},{"issue":"10","key":"3700_CR38","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1136\/annrheumdis-2015-207872","volume":"75","author":"C Gabay","year":"2016","unstructured":"Gabay C, McInnes IB, Kavanaugh A, Tuckwell K, Klearman M, Pulley J, et al. Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis. Ann Rheum Dis. 2016;75(10):1806\u201312.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3700_CR39","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1136\/annrheumdis-2013-204345","volume":"74","author":"IB McInnes","year":"2015","unstructured":"McInnes IB, Thompson L, Giles JT, Bathon JM, Salmon JE, Beaulieu AD, et al. Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study. Ann Rheum Dis. 2015;74(4):694\u2013702.","journal-title":"Ann Rheum Dis"},{"key":"3700_CR40","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.trsl.2016.12.003","volume":"183","author":"P Ruiz-Lim\u00f3n","year":"2017","unstructured":"Ruiz-Lim\u00f3n P, Ortega R, Arias de la Rosa I, Abalos-Aguilera MDC, Perez- Sanchez C, Jimenez- Gomez Y, et al. Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation. Transl Res. 2017;183:87\u2013103.","journal-title":"Transl Res"},{"key":"3700_CR41","doi-asserted-by":"publisher","unstructured":"Bacchiega BC, Bacchiega AB, Usnayo MJ, Bedirian R, Singh G, Pinheiro GD. Interleukin 6 inhibition and coronary artery disease in a high-risk population: a prospective community-based clinical study. J Am Heart Assoc. 2017;6(3):e005038. https:\/\/doi.org\/10.1161\/JAHA.116.005038.","DOI":"10.1161\/JAHA.116.005038"},{"issue":"11","key":"3700_CR42","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00296-010-1500-8","volume":"31","author":"H Yoshida","year":"2011","unstructured":"Yoshida H, Hashizume M, Suzuki M, Mihara M. Induction of high-dose tolerance to the rat anti-mouse IL-6 receptor antibody in NZB\/NZW F1 mice. Rheumatol Int. 2011;31(11):1445\u20139.","journal-title":"Rheumatol Int"},{"issue":"1","key":"3700_CR43","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/ard.2007.086561","volume":"68","author":"MG Perry","year":"2009","unstructured":"Perry MG, Kirwan JR, Jessop DS, Hunt LP. Overnight variations in cortisol, interleukin 6, tumour necrosis factor alpha and other cytokines in people with rheumatoid arthritis. Ann Rheum Dis. 2009;68(1):63\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3700_CR44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1084\/jem.20020439","volume":"196","author":"H Ji","year":"2002","unstructured":"Ji H, Pettit A, Ohmura K, Ortiz-Lopez A, Duchatelle V, Degott C, et al. Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis. J Exp Med. 2002;196(1):77\u201385.","journal-title":"J Exp Med"},{"issue":"6","key":"3700_CR45","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00395-014-0449-2","volume":"109","author":"K Savvatis","year":"2014","unstructured":"Savvatis K, M\u00fcller I, Fr\u00f6hlich M, Pappritz K, Zietsch C, Hamdani N, et al. Interleukin-6 receptor inhibition modulates the immune reaction and restores titin phosphorylation in experimental myocarditis. Basic Res Cardiol. 2014;109(6):449.","journal-title":"Basic Res Cardiol"},{"issue":"2","key":"3700_CR46","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cardfail.2014.11.004","volume":"21","author":"N Glezeva","year":"2015","unstructured":"Glezeva N, Voon V, Watson C, Horgan S, McDonald K, Ledwidge M, et al. Exaggerated inflammation and monocytosis associate with diastolic dysfunction in heart failure with preserved ejection fraction: evidence of M2 macrophage activation in disease pathogenesis. J Card Fail. 2015;21(2):167\u201377.","journal-title":"J Card Fail"},{"issue":"9","key":"3700_CR47","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1161\/CIRCULATIONAHA.123.064974","volume":"149","author":"S Prapiadou","year":"2024","unstructured":"Prapiadou S, \u017divkovi\u0107 L, Thorand B, George MJ, van der Laan SW, Malik R, et al. Proteogenomic data integration reveals CXCL10 as a potentially downstream causal mediator for IL-6 signaling on atherosclerosis. Circulation. 2024;149(9):669\u201383.","journal-title":"Circulation"},{"key":"3700_CR48","doi-asserted-by":"publisher","first-page":"104883","DOI":"10.1016\/j.ebiom.2023.104883","volume":"98","author":"Y Al-Adwi","year":"2023","unstructured":"Al-Adwi Y, Atzeni IM, Doornbos-van der Meer B, van der Leij MJ, Varkevisser RDM, Kroesen BJ, et al. High serum C-X-C motif chemokine ligand 10 (CXCL10) levels may be associated with new onset interstitial lung disease in patients with systemic sclerosis: evidence from observational, clinical, transcriptomic and in vitro studies. EBioMedicine. 2023;98:104883.","journal-title":"EBioMedicine"},{"issue":"1","key":"3700_CR49","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.122.062551","volume":"149","author":"P Ma","year":"2024","unstructured":"Ma P, Liu J, Qin J, Lai L, Heo GS, Luehmann H, et al. Expansion of pathogenic cardiac macrophages in immune checkpoint inhibitor myocarditis. Circulation. 2024;149(1):48\u201366.","journal-title":"Circulation"},{"issue":"2","key":"3700_CR50","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0002-9440(10)63309-3","volume":"165","author":"K Kaikita","year":"2004","unstructured":"Kaikita K, Hayasaki T, Okuma T, Kuziel WA, Ogawa H, Takeya M. Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction. Am J Pathol. 2004;165(2):439\u201347.","journal-title":"Am J Pathol"},{"issue":"2","key":"3700_CR51","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S0735-1097(96)81794-3","volume":"3","author":"B Patel","year":"2018","unstructured":"Patel B, Bansal SS, Ismahil MA, Hamid T, Rokosh G, Mack M, et al. Ccr2(+) monocyte-derived infiltrating macrophages are required for adverse cardiac remodeling during pressure overload. JACC: Basic to Translational Science. 2018;3(2):230\u201344.","journal-title":"JACC: Basic to Translational Science"},{"issue":"1","key":"3700_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11897-010-0004-x","volume":"7","author":"RA de Boer","year":"2010","unstructured":"de Boer RA, Yu L, van Veldhuisen DJ. Galectin-3 in cardiac remodeling and heart failure. Curr Heart Fail Rep. 2010;7(1):1\u20138.","journal-title":"Curr Heart Fail Rep"},{"issue":"1","key":"3700_CR53","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/HJH.0000000000000358","volume":"33","author":"GE Gonz\u00e1lez","year":"2015","unstructured":"Gonz\u00e1lez GE, Rhaleb NE, D\u2019Ambrosio MA, Nakagawa P, Liu Y, Leung P, et al. Deletion of interleukin-6 prevents cardiac inflammation, fibrosis and dysfunction without affecting blood pressure in angiotensin II-high salt-induced hypertension. J Hypertens. 2015;33(1):144\u201352.","journal-title":"J Hypertens"},{"issue":"19","key":"3700_CR54","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","volume":"110","author":"UC Sharma","year":"2004","unstructured":"Sharma UC, Pokharel S, van Brakel TJ, van Berlo JH, Cleutjens JP, Schroen B, et al. Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation. 2004;110(19):3121\u20138.","journal-title":"Circulation"},{"issue":"2","key":"3700_CR55","doi-asserted-by":"publisher","first-page":"H404","DOI":"10.1152\/ajpheart.00747.2008","volume":"296","author":"Y-H Liu","year":"2009","unstructured":"Liu Y-H, D\u2019Ambrosio M, Liao T-d, Peng H, Rhaleb N-E, Sharma U, et al. N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion\/growth-regulatory lectin. Am J Physiol Heart Circulatory Physiol. 2009;296(2):H404\u201312.","journal-title":"Am J Physiol Heart Circulatory Physiol"},{"issue":"2","key":"3700_CR56","doi-asserted-by":"publisher","first-page":"288","DOI":"10.2353\/ajpath.2008.070726","volume":"172","author":"NC Henderson","year":"2008","unstructured":"Henderson NC, Mackinnon AC, Farnworth SL, Kipari T, Haslett C, Iredale JP, et al. Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. Am J Pathol. 2008;172(2):288\u201398.","journal-title":"Am J Pathol"},{"issue":"13","key":"3700_CR57","doi-asserted-by":"publisher","first-page":"5060","DOI":"10.1073\/pnas.0511167103","volume":"103","author":"NC Henderson","year":"2006","unstructured":"Henderson NC, Mackinnon AC, Farnworth SL, Poirier F, Russo FP, Iredale JP, et al. Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci U S A. 2006;103(13):5060\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"3700_CR58","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1002\/art.24574","volume":"60","author":"A Filer","year":"2009","unstructured":"Filer A, Bik M, Parsonage GN, Fitton J, Trebilcock E, Howlett K, et al. Galectin 3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathways. Arthritis Rheum. 2009;60(6):1604\u201314.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3700_CR59","first-page":"893","volume":"35","author":"M Suzuki","year":"2017","unstructured":"Suzuki M, Tanaka K, Yoshida H, Yogo K, Matsumoto Y. Obesity does not diminish the efficacy of IL-6 signalling blockade in mice with collagen-induced arthritis. Clin Exp Rheumatol. 2017;35(6):893\u20138.","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"3700_CR60","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/s44321-025-00227-1","volume":"17","author":"A Margraf","year":"2025","unstructured":"Margraf A, Chen J, Christoforou M, Claria-Ribas P, Henriques Schneider A, Cecconello C, et al. Formyl-peptide receptor type 2 activation mitigates heart and lung damage in inflammatory arthritis. EMBO Mol Med. 2025;17(5):1153\u201383.","journal-title":"EMBO Mol Med"},{"issue":"4","key":"3700_CR61","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1161\/ATVBAHA.123.320326","volume":"44","author":"V Osinski","year":"2024","unstructured":"Osinski V, Yellamilli A, Firulyova MM, Zhang MJ, Peck AL, Auger JL, et al. Profibrotic VEGFR3-dependent lymphatic vessel growth in autoimmune valvular carditis. Arterioscler Thromb Vasc Biol. 2024;44(4):807\u201321.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"3700_CR62","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","volume":"62","author":"WJ Paulus","year":"2013","unstructured":"Paulus WJ, Tsch\u00f6pe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62(4):263\u201371.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"3700_CR63","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-017-0660-3","volume":"19","author":"LF Shirazi","year":"2017","unstructured":"Shirazi LF, Bissett J, Romeo F, Mehta JL. Role of inflammation in heart failure. Curr Atheroscler Rep. 2017;19(6):27.","journal-title":"Curr Atheroscler Rep"},{"issue":"6","key":"3700_CR64","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10741-010-9168-4","volume":"15","author":"M Hedayat","year":"2010","unstructured":"Hedayat M, Mahmoudi MJ, Rose NR, Rezaei N. Proinflammatory cytokines in heart failure: double-edged swords. Heart Fail Rev. 2010;15(6):543\u201362.","journal-title":"Heart Fail Rev"},{"issue":"3","key":"3700_CR65","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/art.27264","volume":"62","author":"C Grundtman","year":"2010","unstructured":"Grundtman C, Hollan I, F\u00f8rre OT, Saatvedt K, Mikkelsen K, Lundberg IE. Cardiovascular disease in patients with inflammatory rheumatic disease is associated with up-regulation of markers of inflammation in cardiac microvessels and cardiomyocytes. Arthritis Rheum. 2010;62(3):667\u201373.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"3700_CR66","doi-asserted-by":"publisher","first-page":"e308","DOI":"10.1093\/ehjci\/jeac134","volume":"23","author":"S Mavrogeni","year":"2022","unstructured":"Mavrogeni S, Pepe A, Nijveldt R, Ntusi N, Sierra-Galan LM, Bratis K, et al. Cardiovascular magnetic resonance in autoimmune rheumatic diseases: a clinical consensus document by the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2022;23(9):e308\u201322.","journal-title":"Eur Heart J Cardiovasc Imaging"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-025-03700-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03700-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03700-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T14:05:47Z","timestamp":1770645947000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13075-025-03700-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3700"],"URL":"https:\/\/doi.org\/10.1186\/s13075-025-03700-x","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"4 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}